Prot #68284528MMY4002: Long-term Follow-up Study for Participants Previously Treated with Ciltacabtagene Autoleucel

Project: Research project

Project Details

StatusActive
Effective start/end date3/20/233/20/26

Funding

  • Parexel (Prot #68284528MMY4002 // Prot #68284528MMY4002)
  • Janssen Research & Development, LLC (Prot #68284528MMY4002 // Prot #68284528MMY4002)